SD Biosensor, Inc (KRX:137310)
9,780.00
+180.00 (1.88%)
At close: Mar 25, 2025, 3:30 PM KST
SD Biosensor Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Operating Revenue | 694,574 | 655,677 | 2,932,001 | 2,929,961 | 1,686,163 | Upgrade
|
Other Revenue | - | -0 | - | - | - | Upgrade
|
Revenue | 694,574 | 655,677 | 2,932,001 | 2,929,961 | 1,686,163 | Upgrade
|
Revenue Growth (YoY) | 5.93% | -77.64% | 0.07% | 73.77% | 2211.01% | Upgrade
|
Cost of Revenue | 357,603 | 533,227 | 1,541,891 | 1,336,785 | 829,530 | Upgrade
|
Gross Profit | 336,971 | 122,449 | 1,390,110 | 1,593,176 | 856,633 | Upgrade
|
Selling, General & Admin | 194,593 | 206,811 | 169,176 | 177,655 | 102,344 | Upgrade
|
Research & Development | 87,946 | 64,203 | 45,762 | 19,086 | 10,388 | Upgrade
|
Other Operating Expenses | 3,229 | 2,810 | 3,527 | 1,571 | 716.9 | Upgrade
|
Operating Expenses | 391,442 | 370,534 | 243,486 | 205,443 | 118,369 | Upgrade
|
Operating Income | -54,471 | -248,085 | 1,146,624 | 1,387,733 | 738,264 | Upgrade
|
Interest Expense | -68,589 | -49,228 | -994.06 | -488.66 | -433.63 | Upgrade
|
Interest & Investment Income | 22,304 | 23,487 | 26,486 | 6,702 | 489.67 | Upgrade
|
Currency Exchange Gain (Loss) | 30,876 | -22,710 | 92,362 | 65,296 | -26,100 | Upgrade
|
Other Non Operating Income (Expenses) | -2,221 | -44,224 | -12,500 | -3,359 | -487.1 | Upgrade
|
EBT Excluding Unusual Items | -72,101 | -340,759 | 1,251,979 | 1,455,883 | 711,734 | Upgrade
|
Gain (Loss) on Sale of Investments | -15,910 | 3,059 | 547.95 | 12,282 | 6,084 | Upgrade
|
Gain (Loss) on Sale of Assets | 4,092 | -1,045 | -1,804 | -1,373 | -580.55 | Upgrade
|
Asset Writedown | -135,262 | -99,869 | -8,634 | -2,283 | - | Upgrade
|
Pretax Income | -219,181 | -438,614 | 1,242,088 | 1,464,509 | 717,237 | Upgrade
|
Income Tax Expense | -121,041 | 29,290 | 333,300 | 376,385 | 95,623 | Upgrade
|
Earnings From Continuing Operations | -98,140 | -467,904 | 908,789 | 1,088,124 | 621,614 | Upgrade
|
Minority Interest in Earnings | -271.22 | 192.56 | 2,574 | 346.26 | -5,978 | Upgrade
|
Net Income | -98,411 | -467,712 | 911,362 | 1,088,471 | 615,636 | Upgrade
|
Net Income to Common | -98,411 | -467,712 | 911,362 | 1,088,471 | 615,636 | Upgrade
|
Net Income Growth | - | - | -16.27% | 76.80% | 19424.28% | Upgrade
|
Shares Outstanding (Basic) | 122 | 111 | 101 | 98 | 93 | Upgrade
|
Shares Outstanding (Diluted) | 122 | 111 | 101 | 98 | 94 | Upgrade
|
Shares Change (YoY) | 10.23% | 9.44% | 3.87% | 4.28% | 13.55% | Upgrade
|
EPS (Basic) | -805.31 | -4218.95 | 8996.76 | 11161.38 | 6597.15 | Upgrade
|
EPS (Diluted) | -805.31 | -4219.00 | 8996.76 | 11161.00 | 6583.00 | Upgrade
|
EPS Growth | - | - | -19.39% | 69.54% | 17223.68% | Upgrade
|
Free Cash Flow | 77,744 | -384,884 | 587,008 | 1,044,892 | 440,478 | Upgrade
|
Free Cash Flow Per Share | 636.19 | -3471.82 | 5794.81 | 10714.52 | 4710.19 | Upgrade
|
Gross Margin | 48.52% | 18.68% | 47.41% | 54.37% | 50.80% | Upgrade
|
Operating Margin | -7.84% | -37.84% | 39.11% | 47.36% | 43.78% | Upgrade
|
Profit Margin | -14.17% | -71.33% | 31.08% | 37.15% | 36.51% | Upgrade
|
Free Cash Flow Margin | 11.19% | -58.70% | 20.02% | 35.66% | 26.12% | Upgrade
|
EBITDA | 87,222 | -110,543 | 1,187,444 | 1,406,848 | 746,239 | Upgrade
|
EBITDA Margin | 12.56% | -16.86% | 40.50% | 48.02% | 44.26% | Upgrade
|
D&A For EBITDA | 141,694 | 137,541 | 40,820 | 19,115 | 7,974 | Upgrade
|
EBIT | -54,471 | -248,085 | 1,146,624 | 1,387,733 | 738,264 | Upgrade
|
EBIT Margin | -7.84% | -37.84% | 39.11% | 47.36% | 43.78% | Upgrade
|
Effective Tax Rate | - | - | 26.83% | 25.70% | 13.33% | Upgrade
|
Advertising Expenses | 4,476 | 5,988 | 14,830 | 10,329 | 2,050 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.